 | • レポートコード：D0GIR-02571 • 出版社/出版日：GlobalInfoResearch / 2020年9月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：New Technology |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、狂犬病モノクローナル抗体の世界市場を広く調査・分析し、今後の市場展望をまとめております。狂犬病モノクローナル抗体の種類別市場規模（カテゴリーIIエクスポージャー、カテゴリーIIIエクスポージャー）、用途別市場規模（大人、子供）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Serum Institute of India、Zydus、NCPC、Crucell、Synermore Biologics ・地域別グローバル市場分析 2015年-2020年 ・狂犬病モノクローナル抗体の北米市場（アメリカ、カナダ、メキシコ） ・狂犬病モノクローナル抗体のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・狂犬病モノクローナル抗体のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・狂犬病モノクローナル抗体の南米市場（ブラジル、アルゼンチン） ・狂犬病モノクローナル抗体の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：カテゴリーIIエクスポージャー、カテゴリーIIIエクスポージャー ・用途別分析：大人、子供 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Rabies Monoclonal Antibody market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Rabies Monoclonal Antibody sales will be xx in 2020 from Rabies Monoclonal Antibody million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Rabies Monoclonal Antibody market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Rabies Monoclonal Antibody industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Rabies Monoclonal Antibody and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Rabies Monoclonal Antibody market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Rabies Monoclonal Antibody market has been segmented into:
Category II Exposure
Category III Exposure
By Application, Rabies Monoclonal Antibody has been segmented into:
Adult
Children
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Rabies Monoclonal Antibody market presented in the report. This section sheds light on the sales growth of different regional and country-level Rabies Monoclonal Antibody markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Rabies Monoclonal Antibody market.
The report offers in-depth assessment of the growth and other aspects of the Rabies Monoclonal Antibody market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Rabies Monoclonal Antibody Market Share Analysis
Rabies Monoclonal Antibody competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Rabies Monoclonal Antibody sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Rabies Monoclonal Antibody sales, revenue and market share for each player covered in this report.
The major players covered in Rabies Monoclonal Antibody are:
Serum Institute of India
Zydus
NCPC
Crucell
Synermore Biologics
Among other players domestic and global, Rabies Monoclonal Antibody market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Rabies Monoclonal Antibody Market Overview
1.1 Product Overview and Scope of Rabies Monoclonal Antibody
1.2 Classification of Rabies Monoclonal Antibody by Type
1.2.1 Global Rabies Monoclonal Antibody Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Rabies Monoclonal Antibody Revenue Market Share by Type in 2019
1.2.3 Category II Exposure
1.2.4 Category III Exposure
1.3 Global Rabies Monoclonal Antibody Market by Application
1.3.1 Overview: Global Rabies Monoclonal Antibody Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Adult
1.3.3 Children
1.4 Global Rabies Monoclonal Antibody Market by Regions
1.4.1 Global Rabies Monoclonal Antibody Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Rabies Monoclonal Antibody (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Rabies Monoclonal Antibody Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Rabies Monoclonal Antibody Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Rabies Monoclonal Antibody Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Rabies Monoclonal Antibody Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Rabies Monoclonal Antibody Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Rabies Monoclonal Antibody Industry Impact
1.5.1 COVID-19 Potential Implications for the Rabies Monoclonal Antibody
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Rabies Monoclonal Antibody
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Serum Institute of India
2.1.1 Serum Institute of India Details
2.1.2 Serum Institute of India Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Serum Institute of India SWOT Analysis
2.1.4 Serum Institute of India Product and Services
2.1.5 Serum Institute of India Rabies Monoclonal Antibody Revenue, Gross Margin and Market Share (2018-2019)
2.2 Zydus
2.2.1 Zydus Details
2.2.2 Zydus Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Zydus SWOT Analysis
2.2.4 Zydus Product and Services
2.2.5 Zydus Rabies Monoclonal Antibody Revenue, Gross Margin and Market Share (2018-2019)
2.3 NCPC
2.3.1 NCPC Details
2.3.2 NCPC Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 NCPC SWOT Analysis
2.3.4 NCPC Product and Services
2.3.5 NCPC Rabies Monoclonal Antibody Revenue, Gross Margin and Market Share (2018-2019)
2.4 Crucell
2.4.1 Crucell Details
2.4.2 Crucell Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Crucell SWOT Analysis
2.4.4 Crucell Product and Services
2.4.5 Crucell Rabies Monoclonal Antibody Revenue, Gross Margin and Market Share (2018-2019)
2.5 Synermore Biologics
2.5.1 Synermore Biologics Details
2.5.2 Synermore Biologics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Synermore Biologics SWOT Analysis
2.5.4 Synermore Biologics Product and Services
2.5.5 Synermore Biologics Rabies Monoclonal Antibody Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Rabies Monoclonal Antibody Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Rabies Monoclonal Antibody Players Market Share
3.2.2 Top 10 Rabies Monoclonal Antibody Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Rabies Monoclonal Antibody Revenue and Market Share by Regions
4.2 North America Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
4.3 Europe Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
4.5 South America Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
5 North America Rabies Monoclonal Antibody Revenue by Countries
5.1 North America Rabies Monoclonal Antibody Revenue by Countries (2015-2020)
5.2 USA Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
5.3 Canada Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
5.4 Mexico Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
6 Europe Rabies Monoclonal Antibody Revenue by Countries
6.1 Europe Rabies Monoclonal Antibody Revenue by Countries (2015-2020)
6.2 Germany Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
6.3 UK Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
6.4 France Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
6.5 Russia Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
6.6 Italy Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Rabies Monoclonal Antibody Revenue by Countries
7.1 Asia-Pacific Rabies Monoclonal Antibody Revenue by Countries (2015-2020)
7.2 China Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
7.3 Japan Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
7.4 Korea Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
7.5 India Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
8 South America Rabies Monoclonal Antibody Revenue by Countries
8.1 South America Rabies Monoclonal Antibody Revenue by Countries (2015-2020)
8.2 Brazil Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
8.3 Argentina Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Rabies Monoclonal Antibody by Countries
9.1 Middle East & Africa Rabies Monoclonal Antibody Revenue by Countries (2015-2020)
9.2 Saudi Arabia Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
9.3 UAE Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
9.4 Egypt Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
9.5 South Africa Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Rabies Monoclonal Antibody Revenue and Market Share by Type (2015-2020)
10.2 Global Rabies Monoclonal Antibody Market Forecast by Type (2019-2024)
10.3 Category II Exposure Revenue Growth Rate (2015-2025)
10.4 Category III Exposure Revenue Growth Rate (2015-2025)
11 Global Rabies Monoclonal Antibody Market Segment by Application
11.1 Global Rabies Monoclonal Antibody Revenue Market Share by Application (2015-2020)
11.2 Rabies Monoclonal Antibody Market Forecast by Application (2019-2024)
11.3 Adult Revenue Growth (2015-2020)
11.4 Children Revenue Growth (2015-2020)
12 Global Rabies Monoclonal Antibody Market Size Forecast (2021-2025)
12.1 Global Rabies Monoclonal Antibody Market Size Forecast (2021-2025)
12.2 Global Rabies Monoclonal Antibody Market Forecast by Regions (2021-2025)
12.3 North America Rabies Monoclonal Antibody Revenue Market Forecast (2021-2025)
12.4 Europe Rabies Monoclonal Antibody Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Rabies Monoclonal Antibody Revenue Market Forecast (2021-2025)
12.6 South America Rabies Monoclonal Antibody Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Rabies Monoclonal Antibody Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Rabies Monoclonal Antibody Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Rabies Monoclonal Antibody by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Rabies Monoclonal Antibody Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Rabies Monoclonal Antibody Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Rabies Monoclonal Antibody Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Serum Institute of India Corporate Information, Location and Competitors
Table 7. Serum Institute of India Rabies Monoclonal Antibody Major Business
Table 8. Serum Institute of India Rabies Monoclonal Antibody Total Revenue (USD Million) (2017-2018)
Table 9. Serum Institute of India SWOT Analysis
Table 10. Serum Institute of India Rabies Monoclonal Antibody Product and Solutions
Table 11. Serum Institute of India Rabies Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Zydus Corporate Information, Location and Competitors
Table 13. Zydus Rabies Monoclonal Antibody Major Business
Table 14. Zydus Rabies Monoclonal Antibody Total Revenue (USD Million) (2018-2019)
Table 15. Zydus SWOT Analysis
Table 16. Zydus Rabies Monoclonal Antibody Product and Solutions
Table 17. Zydus Rabies Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. NCPC Corporate Information, Location and Competitors
Table 19. NCPC Rabies Monoclonal Antibody Major Business
Table 20. NCPC Rabies Monoclonal Antibody Total Revenue (USD Million) (2017-2018)
Table 21. NCPC SWOT Analysis
Table 22. NCPC Rabies Monoclonal Antibody Product and Solutions
Table 23. NCPC Rabies Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Crucell Corporate Information, Location and Competitors
Table 25. Crucell Rabies Monoclonal Antibody Major Business
Table 26. Crucell Rabies Monoclonal Antibody Total Revenue (USD Million) (2017-2018)
Table 27. Crucell SWOT Analysis
Table 28. Crucell Rabies Monoclonal Antibody Product and Solutions
Table 29. Crucell Rabies Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Synermore Biologics Corporate Information, Location and Competitors
Table 31. Synermore Biologics Rabies Monoclonal Antibody Major Business
Table 32. Synermore Biologics Rabies Monoclonal Antibody Total Revenue (USD Million) (2017-2018)
Table 33. Synermore Biologics SWOT Analysis
Table 34. Synermore Biologics Rabies Monoclonal Antibody Product and Solutions
Table 35. Synermore Biologics Rabies Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Global Rabies Monoclonal Antibody Revenue (Million USD) by Players (2015-2020)
Table 37. Global Rabies Monoclonal Antibody Revenue Share by Players (2015-2020)
Table 38. Global Rabies Monoclonal Antibody Revenue (Million USD) by Regions (2015-2020)
Table 39. Global Rabies Monoclonal Antibody Revenue Market Share by Regions (2015-2020)
Table 40. North America Rabies Monoclonal Antibody Revenue by Countries (2015-2020)
Table 41. North America Rabies Monoclonal Antibody Revenue Market Share by Countries (2015-2020)
Table 42. Europe Rabies Monoclonal Antibody Revenue (Million USD) by Countries (2015-2020)
Table 43. Asia-Pacific Rabies Monoclonal Antibody Revenue (Million USD) by Countries (2015-2020)
Table 44. South America Rabies Monoclonal Antibody Revenue by Countries (2015-2020)
Table 45. South America Rabies Monoclonal Antibody Revenue Market Share by Countries (2015-2020)
Table 46. Middle East and Africa Rabies Monoclonal Antibody Revenue (Million USD) by Countries (2015-2020)
Table 47. Middle East and Africa Rabies Monoclonal Antibody Revenue Market Share by Countries (2015-2020)
Table 48. Global Rabies Monoclonal Antibody Revenue (Million USD) by Type (2015-2020)
Table 49. Global Rabies Monoclonal Antibody Revenue Share by Type (2015-2020)
Table 50. Global Rabies Monoclonal Antibody Revenue Forecast by Type (2021-2025)
Table 51. Global Rabies Monoclonal Antibody Revenue by Application (2015-2020)
Table 52. Global Rabies Monoclonal Antibody Revenue Share by Application (2015-2020)
Table 53. Global Rabies Monoclonal Antibody Revenue Forecast by Application (2021-2025)
Table 54. Global Rabies Monoclonal Antibody Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Rabies Monoclonal Antibody Picture
Figure 2. Global Rabies Monoclonal Antibody Revenue Market Share by Type in 2019
Figure 3. Category II Exposure Picture
Figure 4. Category III Exposure Picture
Figure 5. Rabies Monoclonal Antibody Revenue Market Share by Application in 2019
Figure 6. Adult Picture
Figure 7. Children Picture
Figure 8. Global Rabies Monoclonal Antibody Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America Rabies Monoclonal Antibody Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe Rabies Monoclonal Antibody Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific Rabies Monoclonal Antibody Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America Rabies Monoclonal Antibody Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa Rabies Monoclonal Antibody Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global Rabies Monoclonal Antibody Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Rabies Monoclonal Antibody Revenue Share by Players in 2019
Figure 16. Global Top 5 Players Rabies Monoclonal Antibody Revenue Market Share in 2019
Figure 17. Global Top 10 Players Rabies Monoclonal Antibody Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global Rabies Monoclonal Antibody Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global Rabies Monoclonal Antibody Revenue Market Share by Regions (2015-2020)
Figure 21. Global Rabies Monoclonal Antibody Revenue Market Share by Regions in 2018
Figure 22. North America Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 23. Europe Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 25. South America Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 27. North America Rabies Monoclonal Antibody Revenue Market Share by Countries (2015-2020)
Figure 28. North America Rabies Monoclonal Antibody Revenue Market Share by Countries in 2019
Figure 29. USA Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 30. Canada Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 31. Mexico Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 32. Europe Rabies Monoclonal Antibody Revenue Market Share by Countries (2015-2020)
Figure 33. Europe Rabies Monoclonal Antibody Revenue Market Share by Countries in 2019
Figure 34. Germany Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 35. UK Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 36. France Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 37. Russia Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 38. Italy Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Rabies Monoclonal Antibody Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific Rabies Monoclonal Antibody Revenue Market Share by Countries in 2019
Figure 41. China Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 42. Japan Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 43. Korea Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 44. India Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 46. South America Rabies Monoclonal Antibody Revenue Market Share by Countries (2015-2020)
Figure 47. South America Rabies Monoclonal Antibody Revenue Market Share by Countries in 2019
Figure 48. Brazil Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 49. Argentina Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa Rabies Monoclonal Antibody Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa Rabies Monoclonal Antibody Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 53. UAE Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 54. Egypt Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 55. South Africa Rabies Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 56. Global Rabies Monoclonal Antibody Revenue Share by Type (2015-2020)
Figure 57. Global Rabies Monoclonal Antibody Revenue Share by Type in 2019
Figure 58. Global Rabies Monoclonal Antibody Market Share Forecast by Type (2021-2025)
Figure 59. Global Category II Exposure Revenue Growth Rate (2015-2020)
Figure 60. Global Category III Exposure Revenue Growth Rate (2015-2020)
Figure 61. Global Rabies Monoclonal Antibody Revenue Share by Application (2015-2020)
Figure 62. Global Rabies Monoclonal Antibody Revenue Share by Application in 2019
Figure 63. Global Rabies Monoclonal Antibody Market Share Forecast by Application (2021-2025)
Figure 64. Global Adult Revenue Growth Rate (2015-2020)
Figure 65. Global Children Revenue Growth Rate (2015-2020)
Figure 66. Global Rabies Monoclonal Antibody Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global Rabies Monoclonal Antibody Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global Rabies Monoclonal Antibody Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America Rabies Monoclonal Antibody Revenue Market Forecast (2021-2025)
Figure 70. Europe Rabies Monoclonal Antibody Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific Rabies Monoclonal Antibody Revenue Market Forecast (2021-2025)
Figure 72. South America Rabies Monoclonal Antibody Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa Rabies Monoclonal Antibody Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
バイオシミラーモノクローナル抗体の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Biosimilar Monoclonal Antibody market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 26.5% in the forecast period of 2020 to 2025 and will expected to reach USD 12060 million by 2025, from USD 4706.7 million in 2019. The Biosi…- 狂犬病抗血清の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Rabies Antiserum market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 馬狂犬病免疫グロブリン（ERIG）の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Equine Rabies Immunoglobulin (ERIG) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…
- 狂犬病免疫グロブリンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Rabies Immune Globulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…
- ヒト狂犬病免疫グロブリン（HRIG）の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Human Rabies Immune Globulin (HRIG) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…